Inari Medical, Inc.
NARI
Peringkat dalam Saham
#3686
Inari Medical, Inc. is a medical technology firm focused on creating,... Inari Medical, Inc. is a medical technology firm focused on creating, producing, promoting, and distributing devices for the minimally invasive management of venous conditions within the United States. Their product portfolio includes ClotTriever, a mechanical thrombectomy solution designed to extract significant clots from major blood vessels, specifically targeting deep vein thrombosis. Another key offering is FlowTriever, a substantial catheter-based aspiration and mechanical thrombectomy system, which addresses pulmonary embolism. The company also provides FlowSaver; FlowStasis, a large-bore suture retention device to manage venous access points; and FlowTriever 2, an enhanced version with a new disk design for efficiently capturing wall-adherent clots and reducing procedure time. Founded in 2011, the company was initially known as Inceptus Newco1 Inc. before rebranding as Inari Medical, Inc. in September 2013. Its corporate headquarters are located in Irvine, California.
Harga Saham
$79.97
Terakhir disinkronkan: 2025-02-19
Kapitalisasi Pasar
$4.57B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Inari Medical, Inc. (NARI)
Kategori
Healthcare
Pendapatan untuk Inari Medical, Inc. (NARI)
Pendapatan pada Sep 2024 TTM: $574.50M
Menurut laporan keuangan terbaru dari Inari Medical, Inc., pendapatan saat ini (TTM) adalah $574.50M. Pada tahun 2022, perusahaan menghasilkan pendapatan sebesar $383.47M peningkatan dibandingkan pendapatan pada tahun 2021 yang sebesar $276.98M. Pendapatan adalah jumlah total yang dihasilkan dari penjualan barang atau jasa. Tidak seperti laba, tidak ada pengeluaran yang dikurangkan.
Riwayat pendapatan Inari Medical, Inc. dari 2018 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Mengubah |
|---|---|---|
| 2026 (TTM) | $574.50M | 16.38% |
| 2023 | $493.63M | 28.73% |
| 2022 | $383.47M | 38.45% |
| 2021 | $276.98M | 98.31% |
| 2020 | $139.67M | 173.17% |
| 2019 | $51.13M | 648.70% |
| 2018 | $6.83M | 0.00% |
Pendapatan untuk perusahaan serupa atau pesaing
| Perusahaan | Pendapatan | Perbedaan Pendapatan | Negara |
|---|---|---|---|
| $46.59B | 8,008.82% |
US
|
|
| $35.48B | 6,076.52% |
IE
|
|
| $25.84B | 4,397.32% |
US
|
|
| $21.00B | 3,554.67% |
US
|
|
| - | - |
DE
|
